The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease

Pediatric Nephrology

Volumn 25, Issue 12, 2010, Pages 2449-2457

  Goto, Miwa ^a,b   Hoxha, Nita ^a,b   Osman, Rania ^a,b   Dell, Katherine MacRae ^a,b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Angiotensin converting enzyme; Animal models; Hypertension; Polycystic kidney disease; Renin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD PRESSURE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGING; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; MALE; MUTATION; PEPTIDYL-DIPEPTIDASE A; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 78449280887     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1621-z     Document Type: Article

References (47)

1. LM Guay-Woodford RA Desmond 2003 Autosomal recessive polycystic kidney disease: the clinical experience in North America Pediatrics 111 1072 1080 10.1542/peds.111.5.1072 12728091
2. Dell KM, McDonald RA, Watkins S, Avner ED (2003) Polycystic kidney disease. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology. Lippincott, Williams & Wilkins, Philadelphia, pp 675-699
3. BS Kaplan J Fay V Shah MJ Dillon TM Barratt 1989 Autosomal recessive polycystic kidney disease Pediatr Nephrol 3 43 49 1:STN:280: DyaK3M%2Fgt1WjsQ%3D%3D 10.1007/BF00859625 2702087
4. JK Phillips D Hopwood RA Loxley K Ghatora JD Coombes YS Tan JL Harrison DJ McKitrick V Holobotvskyy LF Arnolda GK Rangan 2007 Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease Kidney Blood Press Res 30 129 144 10.1159/000101828 17446713
5. M Loghman-Adham CE Soto T Inagami C Sotelo-Avila 2005 Expression of components of the Renin-Angiotensin system in autosomal recessive polycystic kidney disease J Histochem Cytochem 53 979 988 1:CAS:528:DC%2BD2MXmvVyqt7c%3D 10.1369/jhc.4A6494.2005 15879580
6. M Paul A Poyan Mehr R Kreutz 2006 Physiology of local renin-angiotensin systems Physiol Rev 86 747 803 1:CAS:528:DC%2BD28XnsFGgtLk%3D 10.1152/physrev.00036.2005 16816138
7. H Kobori M Nangaku LG Navar A Nishiyama 2007 The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease Pharmacol Rev 59 251 287 1:CAS:528:DC%2BD2sXht1ahsr3E 10.1124/pr.59.3.3 17878513
8. LG Navar 2004 The intrarenal renin-angiotensin system in hypertension Kidney Int 65 1522 1532 10.1111/j.1523-1755.2004.00539.x 15086502
9. LF Onuchic L Furu Y Nagasawa X Hou T Eggermann Z Ren C Bergmann J Senderek E Esquivel R Zeltner S Rudnik-Schoneborn M Mrug W Sweeney ED Avner K Zerres LM Guay-Woodford S Somlo GG Germino 2002 PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats Am J Hum Genet 70 1305 1317 1:CAS:528:DC%2BD38XjsFGnsL0%3D 10.1086/340448 11898128
10. CJ Ward MC Hogan S Rossetti D Walker T Sneddon X Wang V Kubly JM Cunningham R Bacallao M Ishibashi DS Milliner VE Torres PC Harris 2002 The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein Nat Genet 30 259 269 10.1038/ng833 11919560
11. SE Whitesall JB Hoff AP Vollmer LG D'Alecy 2004 Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods Am J Physiol Heart Circ Physiol 286 H2408 H2415 1:CAS:528:DC%2BD2cXkvFCrurg%3D 10.1152/ajpheart.01089.2003 14962829
12. TW Kurtz KA Griffin AK Bidani RL Davisson JE Hall 2005 Recommendations for blood pressure measurement in humans and experimental animals. II. Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research Hypertension 45 299 310 1:CAS:528:DC%2BD2MXmtVWntw%3D%3D 10.1161/01.HYP.0000150857.39919.cb 15611363
13. DJ Lager Q Qian RJ Bengal M Ishibashi VE Torres 2001 The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease Kidney Int 59 126 136 1:STN:280:DC%2BD3M7jtFWktg%3D%3D 10.1046/j.1523-1755.2001.00473.x 11135065
14. VE Torres WE Sweeney Jr X Wang Q Qian PC Harris P Frost ED Avner 2004 Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats Kidney Int 66 1766 1773 1:CAS:528:DC%2BD2cXhtVCgs7vL 10.1111/j.1523-1755.2004.00952.x 15496147
15. X Wang V Gattone 2nd PC Harris VE Torres 2005 Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat J Am Soc Nephrol 16 846 851 1:CAS:528:DC%2BD2MXjsVWqsLc%3D 10.1681/ASN.2004121090 15728778
16. JG Blickman RT Bramson JT Herrin 1995 Autosomal recessive polycystic kidney disease: long-term sonographic findings in patients surviving the neonatal period AJR Am J Roentgenol 164 1247 1250 1:STN:280:DyaK2M3jtlaksg%3D%3D 7717240
17. DK Boal RL Teele 1980 Sonography of infantile polycystic kidney disease Am J Radiol 135 575 580 1:STN:280:DyaL3c3mt1Oktg%3D%3D
18. ML Graciano C Cavaglieri Rde H Delle WV Dominguez DE Casarini DM Malheiros IL Noronha 2004 Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis J Am Soc Nephrol 15 1805 1815 1:CAS:528: DC%2BD2cXltVOjtbo%3D 10.1097/01.ASN.0000131528.00773.A9 15213268
19. RE Gilbert LL Wu DJ Kelly A Cox JL Wilkinson-Berka CI Johnston ME Cooper 1999 Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis Am J Pathol 155 429 440 1:CAS:528:DyaK1MXls1ansLw%3D 10433936
20. LG Navar LM Harrison-Bernard A Nishiyama H Kobori 2002 Regulation of intrarenal angiotensin II in hypertension Hypertension 39 316 322 1:CAS:528:DC%2BD38Xhs1Wls7k%3D 10.1161/hy0202.103821 11882566
21. U Tox HM Steffen 2006 Impact of inhibitors of the Renin-Angiotensin- aldosterone system on liver fibrosis and portal hypertension Curr Med Chem 13 3649 3661 1:STN:280:DC%2BD28jjtFCiuw%3D%3D 10.2174/092986706779026138 17168728
22. H Yoshiji H Fukui 2006 Renin-angiotensin system and progression of chronic liver diseases J Gastroenterol 41 1020 1022 10.1007/s00535-006-1897-8 17096072
23. CM Ferrario M Paul A Poyan Mehr R Kreutz M Tokmakova SD Solomon 2006 Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. Physiology of local renin-angiotensin systems inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials J Renin Angiotensin Aldosterone Syst 7 3 14 1:CAS:528:DC%2BD28XmtlKgtLk%3D 10.3317/jraas.2006.003 17083068
24. C Ruster G Wolf 2006 Renin-angiotensin-aldosterone system and progression of renal disease J Am Soc Nephrol 17 2985 2991 10.1681/ASN.2006040356 17035613
25. M Goto N Hoxha R Osman J Wen R Wells KM Dell 2010 Renin-angiotensin system (RAS) activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease (ARPKD) Pediatr Gastroenterol 50 639 644 1:CAS:528:DC%2BC3cXmsFCjs74%3D 10.1097/MPG.0b013e3181cc80e4
26. IV Yosipiv SS El-Dahr 1996 Activation of angiotensin-generating systems in the developing rat kidney Hypertension 27 281 286 1:CAS:528: DyaK28Xhs1Sgsbc%3D 8567053
27. JL Ricker VH Gattone 2nd JP Calvet CA Rankin 2000 Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice J Am Soc Nephrol 11 1837 1847 1:CAS:528:DC%2BD3cXnsVCku7k%3D 11004214
28. K Nakanishi W Sweeney Jr ED Avner 2001 Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease J Am Soc Nephrol 12 379 384 1:CAS:528:DC%2BD3MXhtl2msLc%3D 11158230
29. Dell KM, Avner ED (2008) In GeneClinics: Clinical Genetic Information Resource [database online]. Copyright, University of Washington, Seattle. Available at http://www.geneclinics.org. Initial posting July 2001, updated 2008
30. MC Prieto-Carrasquero FT Botros J Pagan H Kobori DM Seth DE Casarini LG Navar 2008 Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip Goldblatt hypertensive rats Hypertension 51 1590 1596 1:CAS:528:DC%2BD1cXlvFaitL4%3D 10.1161/HYPERTENSIONAHA.108.110916 18426992
31. MC Prieto-Carrasquero FT Botros H Kobori LG Navar 2009 Collecting duct renin: a major player in angiotensin II-dependent hypertension J Am Soc Hypertens 3 96 104 10.1016/j.jash.2008.11.003 20046983
32. AB Chapman A Johnson PA Gabow RW Schrier 1990 The renin-angiotensin- aldosterone system and autosomal dominant polycystic kidney disease N Engl J Med 323 1091 1096 1:STN:280:DyaK3M%2FhsFaiug%3D%3D 10.1056/NEJM199010183231602 2215576
33. M Eyries M Agrapart A Alonso F Soubrier 2002 Phorbol ester induction of angiotensin-converting enzyme transcription is mediated by Egr-1 and AP-1 in human endothelial cells via ERK1/2 pathway Circ Res 91 899 906 1:CAS:528:DC%2BD38XosFWnsrw%3D 10.1161/01.RES.0000042703.39845.B4 12433834
34. J Xavier-Neto AC Pereira ML Junqueira R Carmona JE Krieger 1999 Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium Hypertension 34 31 38 1:CAS:528:DyaK1MXkvFejtbk%3D 10406820
35. B Neubauer K Machura M Chen LS Weinstein M Oppermann ML Sequeira-Lopez RA Gomez J Schnermann H Castrop A Kurtz C Wagner 2009 Development of vascular renin expression in the kidney critically depends on the cyclic AMP pathway Am J Physiol Renal Physiol 296 F1006 F1012 1:CAS:528:DC%2BD1MXlvFantbk%3D 10.1152/ajprenal.90448.2008 19261741
36. FA Belibi G Reif DP Wallace T Yamaguchi L Olsen H Li GM Helmkamp Jr. JJ Grantham 2004 Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells Kidney Int 66 964 973 1:CAS:528:DC%2BD2cXnvVCrt7s%3D 10.1111/j.1523-1755.2004.00843.x 15327388
37. VE Torres 2004 Cyclic AMP, at the hub of the cystic cycle Kidney Int 66 1283 1285 10.1111/j.1523-1755.2004.00945.x 15327429
38. BD Cowley Jr 2008 Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease Kidney Int 73 251 253 1:CAS:528:DC%2BD1cXmsVylsw%3D%3D 10.1038/sj.ki.5002695 18195694 discussion 269
39. EI Veizis CR Carlin CU Cotton 2004 Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice Am J Physiol Renal Physiol 286 F244 F254 1:CAS:528:DC%2BD2cXhsFKqs74%3D 10.1152/ajprenal.00169.2003 14559716
40. D Olteanu BK Yoder W Liu MJ Croyle EA Welty K Rosborough JM Wyss PD Bell LM Guay-Woodford MO Bevensee LM Satlin EM Schwiebert 2006 Heightened epithelial Na+ channel-mediated Na+ absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia Am J Physiol Cell Physiol 290 C952 C963 1:CAS:528:DC%2BD28Xks1Sms7g%3D 10.1152/ajpcell.00339.2005 16207792
41. E Wuhl O Mehls F Schaefer 2004 Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure Kidney Int 66 768 776 10.1111/j.1523-1755.2004.00802.x 15253732
42. S Dutta A Narang 2003 Enalapril-induced acute renal failure in a newborn infant Pediatr Nephrol 18 570 572 12698328
43. RD Colavita KM Gaudio NJ Siegel 1983 Reversible reduction in renal function during treatment with captopril Pediatrics 71 839 840 1:STN:280:DyaL3s7mvVKmtg%3D%3D 6340052
44. AB Chapman PA Gabow RW Schrier 1991 Reversible renal failure associated with angiotensin-converting enzyme inhibitors in polycystic kidney disease Ann Intern Med 115 769 773 1:STN:280:DyaK38%2Fislagsg%3D%3D 1929024
45. EP Bottinger M Bitzer 2002 TGF-beta signaling in renal disease J Am Soc Nephrol 13 2600 2610 10.1097/01.ASN.0000033611.79556.AE 12239251
46. G Wolf 2006 Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway Kidney Int 70 1914 1919 1:CAS:528:DC%2BD28Xht1Cls7nP 16985515
47. AB Chapman 2008 Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies Clin J Am Soc Nephrol 3 1197 1204 1:CAS:528:DC%2BD1cXovFeksro%3D 10.2215/CJN.00060108 18579674